BNP Paribas Arbitrage SA Has $5.21 Million Stake in Healthcare Trust of America, Inc. (HTA)

BNP Paribas Arbitrage SA grew its stake in Healthcare Trust of America, Inc. (NYSE:HTA) by 176.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 174,959 shares of the real estate investment trust’s stock after acquiring an additional 111,726 shares during the period. BNP Paribas Arbitrage SA owned 0.09% of Healthcare Trust of America worth $5,214,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in HTA. Vanguard Group Inc. grew its holdings in shares of Healthcare Trust of America by 34.1% in the 2nd quarter. Vanguard Group Inc. now owns 29,518,137 shares of the real estate investment trust’s stock valued at $918,310,000 after acquiring an additional 7,510,727 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Healthcare Trust of America by 5,675.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 6,025,724 shares of the real estate investment trust’s stock valued at $187,461,000 after acquiring an additional 5,921,387 shares in the last quarter. BlackRock Inc. grew its holdings in shares of Healthcare Trust of America by 44.3% in the 2nd quarter. BlackRock Inc. now owns 13,050,386 shares of the real estate investment trust’s stock valued at $405,999,000 after acquiring an additional 4,003,376 shares in the last quarter. FMR LLC grew its holdings in shares of Healthcare Trust of America by 220.0% in the 2nd quarter. FMR LLC now owns 4,605,600 shares of the real estate investment trust’s stock valued at $143,280,000 after acquiring an additional 3,166,400 shares in the last quarter. Finally, Cbre Clarion Securities LLC grew its holdings in shares of Healthcare Trust of America by 56.9% in the 2nd quarter. Cbre Clarion Securities LLC now owns 8,181,898 shares of the real estate investment trust’s stock valued at $254,539,000 after acquiring an additional 2,965,936 shares in the last quarter. Institutional investors own 97.88% of the company’s stock.

HTA has been the subject of several analyst reports. BidaskClub upgraded Healthcare Trust of America from a “sell” rating to a “hold” rating in a report on Saturday, August 26th. Zacks Investment Research cut Healthcare Trust of America from a “hold” rating to a “sell” rating in a report on Wednesday, September 6th. FBR & Co set a $32.00 price target on Healthcare Trust of America and gave the stock a “hold” rating in a report on Wednesday, October 11th. Jefferies Group LLC reiterated a “buy” rating and set a $34.00 price target on shares of Healthcare Trust of America in a report on Tuesday, October 3rd. Finally, SunTrust Banks, Inc. set a $36.00 price target on Healthcare Trust of America and gave the stock a “buy” rating in a report on Tuesday, October 24th. Five analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $34.20.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece of content on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The legal version of this piece of content can be read at https://ledgergazette.com/2017/11/18/bnp-paribas-arbitrage-sa-has-5-21-million-stake-in-healthcare-trust-of-america-inc-hta.html.

Shares of Healthcare Trust of America, Inc. (NYSE HTA) opened at $30.56 on Friday. Healthcare Trust of America, Inc. has a 1-year low of $27.47 and a 1-year high of $33.00. The stock has a market capitalization of $6,260.00, a P/E ratio of 18.69, a PEG ratio of 4.65 and a beta of 0.31. The company has a current ratio of 1.30, a quick ratio of 1.30 and a debt-to-equity ratio of 0.88.

Healthcare Trust of America (NYSE:HTA) last issued its quarterly earnings data on Tuesday, October 24th. The real estate investment trust reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.41 by ($0.34). Healthcare Trust of America had a return on equity of 1.50% and a net margin of 6.75%. The firm had revenue of $176.00 million for the quarter, compared to the consensus estimate of $163.62 million. During the same quarter in the prior year, the firm earned $0.40 EPS. The company’s revenue was up 48.8% on a year-over-year basis. equities research analysts expect that Healthcare Trust of America, Inc. will post 1.65 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 9th. Stockholders of record on Tuesday, January 2nd will be issued a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a dividend yield of 3.99%. The ex-dividend date of this dividend is Friday, December 29th. Healthcare Trust of America’s dividend payout ratio is presently 508.33%.

Healthcare Trust of America Company Profile

Healthcare Trust of America, Inc is a real estate investment trust. The Company is an owner and operator of medical office buildings (MOBs) in the United States. The Company focuses on owning and operating MOBs that serve healthcare delivery and are located on health system campuses, near university medical centers, or in community core outpatient locations.

Want to see what other hedge funds are holding HTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthcare Trust of America, Inc. (NYSE:HTA).

Institutional Ownership by Quarter for Healthcare Trust of America (NYSE:HTA)

Receive News & Ratings for Healthcare Trust of America Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Trust of America Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply